世界のグリコーゲン代謝性疾患市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glycogen Metabolism Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2595
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、グリコーゲン代謝性疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・グリコーゲン代謝性疾患の市場動向
・企業の競争状況、市場シェア
・グリコーゲン代謝性疾患の種類別市場規模（OTC、Rx薬）
・グリコーゲン代謝性疾患の用途別市場規模（病院、小売薬局）
・グリコーゲン代謝性疾患の北米市場規模2016-2027（アメリカ、カナダ）
・グリコーゲン代謝性疾患のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・グリコーゲン代謝性疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・グリコーゲン代謝性疾患の中南米市場規模2016-2027（メキシコ、ブラジル）
・グリコーゲン代謝性疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、Novartis、Takeda Pharmaceutical、Astra Zeneca、Boehringer Ingelheim、KOWA、Kythera、Fuji yakuhin、LG Life Science、Metsubishi Tanabe Pharma）
・結論

Diabetes mellitus is the main disease of Glycogen Metabolism Disease.

Market Analysis and Insights: Global Glycogen Metabolism Disease Market
The global Glycogen Metabolism Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glycogen Metabolism Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glycogen Metabolism Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glycogen Metabolism Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glycogen Metabolism Disease market.

Global Glycogen Metabolism Disease Scope and Market Size
Glycogen Metabolism Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glycogen Metabolism Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Retail Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Boehringer Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycogen Metabolism Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Glycogen Metabolism Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glycogen Metabolism Disease Market Perspective (2016-2027)
2.2 Glycogen Metabolism Disease Growth Trends by Regions
2.2.1 Glycogen Metabolism Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glycogen Metabolism Disease Historic Market Share by Regions (2016-2021)
2.2.3 Glycogen Metabolism Disease Forecasted Market Size by Regions (2022-2027)
2.3 Glycogen Metabolism Disease Industry Dynamic
2.3.1 Glycogen Metabolism Disease Market Trends
2.3.2 Glycogen Metabolism Disease Market Drivers
2.3.3 Glycogen Metabolism Disease Market Challenges
2.3.4 Glycogen Metabolism Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glycogen Metabolism Disease Players by Revenue
3.1.1 Global Top Glycogen Metabolism Disease Players by Revenue (2016-2021)
3.1.2 Global Glycogen Metabolism Disease Revenue Market Share by Players (2016-2021)
3.2 Global Glycogen Metabolism Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glycogen Metabolism Disease Revenue
3.4 Global Glycogen Metabolism Disease Market Concentration Ratio
3.4.1 Global Glycogen Metabolism Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycogen Metabolism Disease Revenue in 2020
3.5 Glycogen Metabolism Disease Key Players Head office and Area Served
3.6 Key Players Glycogen Metabolism Disease Product Solution and Service
3.7 Date of Enter into Glycogen Metabolism Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glycogen Metabolism Disease Breakdown Data by Type
4.1 Global Glycogen Metabolism Disease Historic Market Size by Type (2016-2021)
4.2 Global Glycogen Metabolism Disease Forecasted Market Size by Type (2022-2027)

5 Glycogen Metabolism Disease Breakdown Data by Application
5.1 Global Glycogen Metabolism Disease Historic Market Size by Application (2016-2021)
5.2 Global Glycogen Metabolism Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glycogen Metabolism Disease Market Size (2016-2027)
6.2 North America Glycogen Metabolism Disease Market Size by Type
6.2.1 North America Glycogen Metabolism Disease Market Size by Type (2016-2021)
6.2.2 North America Glycogen Metabolism Disease Market Size by Type (2022-2027)
6.2.3 North America Glycogen Metabolism Disease Market Size by Type (2016-2027)
6.3 North America Glycogen Metabolism Disease Market Size by Application
6.3.1 North America Glycogen Metabolism Disease Market Size by Application (2016-2021)
6.3.2 North America Glycogen Metabolism Disease Market Size by Application (2022-2027)
6.3.3 North America Glycogen Metabolism Disease Market Size by Application (2016-2027)
6.4 North America Glycogen Metabolism Disease Market Size by Country
6.4.1 North America Glycogen Metabolism Disease Market Size by Country (2016-2021)
6.4.2 North America Glycogen Metabolism Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Glycogen Metabolism Disease Market Size (2016-2027)
7.2 Europe Glycogen Metabolism Disease Market Size by Type
7.2.1 Europe Glycogen Metabolism Disease Market Size by Type (2016-2021)
7.2.2 Europe Glycogen Metabolism Disease Market Size by Type (2022-2027)
7.2.3 Europe Glycogen Metabolism Disease Market Size by Type (2016-2027)
7.3 Europe Glycogen Metabolism Disease Market Size by Application
7.3.1 Europe Glycogen Metabolism Disease Market Size by Application (2016-2021)
7.3.2 Europe Glycogen Metabolism Disease Market Size by Application (2022-2027)
7.3.3 Europe Glycogen Metabolism Disease Market Size by Application (2016-2027)
7.4 Europe Glycogen Metabolism Disease Market Size by Country
7.4.1 Europe Glycogen Metabolism Disease Market Size by Country (2016-2021)
7.4.2 Europe Glycogen Metabolism Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glycogen Metabolism Disease Market Size (2016-2027)
8.2 Asia-Pacific Glycogen Metabolism Disease Market Size by Type
8.2.1 Asia-Pacific Glycogen Metabolism Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glycogen Metabolism Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glycogen Metabolism Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Glycogen Metabolism Disease Market Size by Application
8.3.1 Asia-Pacific Glycogen Metabolism Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glycogen Metabolism Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glycogen Metabolism Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Glycogen Metabolism Disease Market Size by Region
8.4.1 Asia-Pacific Glycogen Metabolism Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glycogen Metabolism Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glycogen Metabolism Disease Market Size (2016-2027)
9.2 Latin America Glycogen Metabolism Disease Market Size by Type
9.2.1 Latin America Glycogen Metabolism Disease Market Size by Type (2016-2021)
9.2.2 Latin America Glycogen Metabolism Disease Market Size by Type (2022-2027)
9.2.3 Latin America Glycogen Metabolism Disease Market Size by Type (2016-2027)
9.3 Latin America Glycogen Metabolism Disease Market Size by Application
9.3.1 Latin America Glycogen Metabolism Disease Market Size by Application (2016-2021)
9.3.2 Latin America Glycogen Metabolism Disease Market Size by Application (2022-2027)
9.3.3 Latin America Glycogen Metabolism Disease Market Size by Application (2016-2027)
9.4 Latin America Glycogen Metabolism Disease Market Size by Country
9.4.1 Latin America Glycogen Metabolism Disease Market Size by Country (2016-2021)
9.4.2 Latin America Glycogen Metabolism Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glycogen Metabolism Disease Market Size (2016-2027)
10.2 Middle East & Africa Glycogen Metabolism Disease Market Size by Type
10.2.1 Middle East & Africa Glycogen Metabolism Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glycogen Metabolism Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glycogen Metabolism Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Glycogen Metabolism Disease Market Size by Application
10.3.1 Middle East & Africa Glycogen Metabolism Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glycogen Metabolism Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glycogen Metabolism Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Glycogen Metabolism Disease Market Size by Country
10.4.1 Middle East & Africa Glycogen Metabolism Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glycogen Metabolism Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Glycogen Metabolism Disease Introduction
11.1.4 Merck Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Glycogen Metabolism Disease Introduction
11.2.4 Novartis Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Glycogen Metabolism Disease Introduction
11.3.4 Takeda Pharmaceutical Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Astra Zeneca Business Overview
11.4.3 Astra Zeneca Glycogen Metabolism Disease Introduction
11.4.4 Astra Zeneca Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.4.5 Astra Zeneca Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Glycogen Metabolism Disease Introduction
11.5.4 Boehringer Ingelheim Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 KOWA
11.6.1 KOWA Company Details
11.6.2 KOWA Business Overview
11.6.3 KOWA Glycogen Metabolism Disease Introduction
11.6.4 KOWA Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.6.5 KOWA Recent Development
11.7 Kythera
11.7.1 Kythera Company Details
11.7.2 Kythera Business Overview
11.7.3 Kythera Glycogen Metabolism Disease Introduction
11.7.4 Kythera Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.7.5 Kythera Recent Development
11.8 Fuji yakuhin
11.8.1 Fuji yakuhin Company Details
11.8.2 Fuji yakuhin Business Overview
11.8.3 Fuji yakuhin Glycogen Metabolism Disease Introduction
11.8.4 Fuji yakuhin Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.8.5 Fuji yakuhin Recent Development
11.9 LG Life Science
11.9.1 LG Life Science Company Details
11.9.2 LG Life Science Business Overview
11.9.3 LG Life Science Glycogen Metabolism Disease Introduction
11.9.4 LG Life Science Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.9.5 LG Life Science Recent Development
11.10 Metsubishi Tanabe Pharma
11.10.1 Metsubishi Tanabe Pharma Company Details
11.10.2 Metsubishi Tanabe Pharma Business Overview
11.10.3 Metsubishi Tanabe Pharma Glycogen Metabolism Disease Introduction
11.10.4 Metsubishi Tanabe Pharma Revenue in Glycogen Metabolism Disease Business (2016-2021)
11.10.5 Metsubishi Tanabe Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glycogen Metabolism Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Glycogen Metabolism Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Glycogen Metabolism Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Glycogen Metabolism Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Glycogen Metabolism Disease Market Share by Regions (2016-2021)
Table 8. Global Glycogen Metabolism Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Glycogen Metabolism Disease Market Share by Regions (2022-2027)
Table 10. Glycogen Metabolism Disease Market Trends
Table 11. Glycogen Metabolism Disease Market Drivers
Table 12. Glycogen Metabolism Disease Market Challenges
Table 13. Glycogen Metabolism Disease Market Restraints
Table 14. Global Glycogen Metabolism Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Glycogen Metabolism Disease Market Share by Players (2016-2021)
Table 16. Global Top Glycogen Metabolism Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycogen Metabolism Disease as of 2020)
Table 17. Ranking of Global Top Glycogen Metabolism Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Glycogen Metabolism Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Glycogen Metabolism Disease Product Solution and Service
Table 21. Date of Enter into Glycogen Metabolism Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Glycogen Metabolism Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Glycogen Metabolism Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Glycogen Metabolism Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Glycogen Metabolism Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Glycogen Metabolism Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Glycogen Metabolism Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Glycogen Metabolism Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Glycogen Metabolism Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Glycogen Metabolism Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Glycogen Metabolism Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Glycogen Metabolism Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Glycogen Metabolism Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Glycogen Metabolism Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Glycogen Metabolism Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Glycogen Metabolism Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Glycogen Metabolism Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Glycogen Metabolism Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Glycogen Metabolism Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Glycogen Metabolism Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Glycogen Metabolism Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Glycogen Metabolism Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Glycogen Metabolism Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Glycogen Metabolism Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Glycogen Metabolism Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glycogen Metabolism Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Glycogen Metabolism Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Glycogen Metabolism Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Glycogen Metabolism Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Glycogen Metabolism Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Glycogen Metabolism Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Glycogen Metabolism Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Glycogen Metabolism Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Glycogen Metabolism Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Glycogen Metabolism Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Glycogen Metabolism Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Glycogen Metabolism Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glycogen Metabolism Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Glycogen Metabolism Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Glycogen Metabolism Disease Product
Table 64. Merck Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Glycogen Metabolism Disease Product
Table 69. Novartis Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Takeda Pharmaceutical Company Details
Table 72. Takeda Pharmaceutical Business Overview
Table 73. Takeda Pharmaceutical Glycogen Metabolism Disease Product
Table 74. Takeda Pharmaceutical Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 75. Takeda Pharmaceutical Recent Development
Table 76. Astra Zeneca Company Details
Table 77. Astra Zeneca Business Overview
Table 78. Astra Zeneca Glycogen Metabolism Disease Product
Table 79. Astra Zeneca Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 80. Astra Zeneca Recent Development
Table 81. Boehringer Ingelheim Company Details
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Glycogen Metabolism Disease Product
Table 84. Boehringer Ingelheim Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 85. Boehringer Ingelheim Recent Development
Table 86. KOWA Company Details
Table 87. KOWA Business Overview
Table 88. KOWA Glycogen Metabolism Disease Product
Table 89. KOWA Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 90. KOWA Recent Development
Table 91. Kythera Company Details
Table 92. Kythera Business Overview
Table 93. Kythera Glycogen Metabolism Disease Product
Table 94. Kythera Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 95. Kythera Recent Development
Table 96. Fuji yakuhin Company Details
Table 97. Fuji yakuhin Business Overview
Table 98. Fuji yakuhin Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 99. Fuji yakuhin Recent Development
Table 100. LG Life Science Company Details
Table 101. LG Life Science Business Overview
Table 102. LG Life Science Glycogen Metabolism Disease Product
Table 103. LG Life Science Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 104. LG Life Science Recent Development
Table 105. Metsubishi Tanabe Pharma Company Details
Table 106. Metsubishi Tanabe Pharma Business Overview
Table 107. Metsubishi Tanabe Pharma Glycogen Metabolism Disease Product
Table 108. Metsubishi Tanabe Pharma Revenue in Glycogen Metabolism Disease Business (2016-2021) & (US$ Million)
Table 109. Metsubishi Tanabe Pharma Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glycogen Metabolism Disease Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Glycogen Metabolism Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Glycogen Metabolism Disease Report Years Considered
Figure 8. Global Glycogen Metabolism Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Glycogen Metabolism Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Glycogen Metabolism Disease Market Share by Regions: 2020 VS 2027
Figure 11. Global Glycogen Metabolism Disease Market Share by Regions (2022-2027)
Figure 12. Global Glycogen Metabolism Disease Market Share by Players in 2020
Figure 13. Global Top Glycogen Metabolism Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycogen Metabolism Disease as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Glycogen Metabolism Disease Revenue in 2020
Figure 15. Global Glycogen Metabolism Disease Revenue Market Share by Type (2016-2021)
Figure 16. Global Glycogen Metabolism Disease Revenue Market Share by Type (2022-2027)
Figure 17. North America Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Glycogen Metabolism Disease Market Share by Type (2016-2027)
Figure 19. North America Glycogen Metabolism Disease Market Share by Application (2016-2027)
Figure 20. North America Glycogen Metabolism Disease Market Share by Country (2016-2027)
Figure 21. United States Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Glycogen Metabolism Disease Market Share by Type (2016-2027)
Figure 25. Europe Glycogen Metabolism Disease Market Share by Application (2016-2027)
Figure 26. Europe Glycogen Metabolism Disease Market Share by Country (2016-2027)
Figure 27. Germany Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Glycogen Metabolism Disease Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Glycogen Metabolism Disease Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Glycogen Metabolism Disease Market Share by Region (2016-2027)
Figure 37. China Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Glycogen Metabolism Disease Market Share by Type (2016-2027)
Figure 45. Latin America Glycogen Metabolism Disease Market Share by Application (2016-2027)
Figure 46. Latin America Glycogen Metabolism Disease Market Share by Country (2016-2027)
Figure 47. Mexico Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Glycogen Metabolism Disease Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Glycogen Metabolism Disease Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Glycogen Metabolism Disease Market Share by Country (2016-2027)
Figure 53. Turkey Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Glycogen Metabolism Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Merck Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 57. Novartis Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 58. Takeda Pharmaceutical Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 59. Astra Zeneca Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 61. KOWA Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 62. Kythera Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 63. Fuji yakuhin Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 64. LG Life Science Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 65. Metsubishi Tanabe Pharma Revenue Growth Rate in Glycogen Metabolism Disease Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のグリコーゲン代謝性疾患治療市場規模・現状・予測（2021年-2027年）

Global Glycogen Metabolism Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2596 2021年4月 98Pages
QYResearch社発行の本調査資料では、グリコーゲン代謝性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の脂質代謝疾患市場規模・現状・予測（2021年-2027年）

Global Lipid Metabolism Disease Market Size, Status and Forecast 2021-2027
QYR2104Z3433 2021年4月 99Pages
QYResearch社発行の本調査資料では、脂質代謝疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南ア...

世界のアミノ酸代謝疾患市場規模・現状・予測（2021年-2027年）

Global Amino Acid Metabolism Disease Market Size, Status and Forecast 2021-2027
QYR2104Z0288 2021年4月 95Pages
QYResearch社発行の本調査資料では、アミノ酸代謝疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、処方薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東...

世界の脂質代謝疾患治療市場規模・現状・予測（2021年-2027年）

Global Lipid Metabolism Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3434 2021年4月 95Pages
QYResearch社発行の本調査資料では、脂質代謝疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東...

世界のアミノ酸代謝疾患治療市場規模・現状・予測（2021年-2027年）

Global Amino Acid Metabolism Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0289 2021年4月 91Pages
QYResearch社発行の本調査資料では、アミノ酸代謝疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、処方薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド...

世界の代謝性疾患治療市場規模・現状・予測（2021年-2027年）

Global Metabolic Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3713 2021年4月 91Pages
QYResearch社発行の本調査資料では、代謝性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別市場規模（病院薬局、小売薬局）、主要地域別市場規模（北...

世界のアミノ酸代謝異常治療市場規模・現状・予測（2021年-2027年）

Global Amino Acid Metabolism Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0290 2021年4月 98Pages
QYResearch社発行の本調査資料では、アミノ酸代謝異常治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルギニン、葉酸、ビタミンB6＆B12、チアミン、ビタミンD、ベタイン、カルグルミン酸、二塩酸塩サプロテリン、その他）、用途別市場規...

世界の代謝検査市場規模・現状・予測（2021年-2027年）

Global Metabolism Testing Market Size, Status and Forecast 2021-2027
QYR2104Z3717 2021年4月 133Pages
QYResearch社発行の本調査資料では、代謝検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（VO2 Max分析、体組成分析、エネルギー代謝率（RMR）分析）、用途別市場規模（GYMテスト、スポーツテスト、集中治療室、生活習慣病、人間パフ...

世界の骨・ミネラル代謝異常治療市場規模・現状・予測（2021年-2027年）

Global Bone and Mineral Metabolism Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0938 2021年4月 91Pages
QYResearch社発行の本調査資料では、骨・ミネラル代謝異常治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスホスホネート、エストロゲン、リン吸着剤、非カルシウム、非金属ベースバインダー、金属ベースバインダー、マグネシウムベースバイン...

世界のリソソーム蓄積症（LSD）市場規模・現状・予測（2021年-2027年）

Global Lysosomal Storage Disease (LSD) Market Size, Status and Forecast 2021-2027
QYR2104Z3508 2021年4月 94Pages
QYResearch社発行の本調査資料では、リソソーム蓄積症（LSD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（脂質代謝異常症、糖タンパク質代謝異常症）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界のグリコーゲン代謝性疾患治療市場規模・現状・予測（2021年-2027年） Diabetes mellitus is the main disease of Glycogen Metabolism Disease. Market Analysis and Insights: Global Glycogen Metabolism Disease Treatment Market The global Glycogen Metabolism Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of…
世界の脂質代謝疾患市場規模・現状・予測（2021年-2027年） Lipid Metabolism Disease Drug is usually used to help lipid metabolism. Market Analysis and Insights: Global Lipid Metabolism Disease Market The global Lipid Metabolism Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. W…
世界のアミノ酸代謝疾患市場規模・現状・予測（2021年-2027年） Amino Acid Metabolism Drug is used to treat the gout and Hyperuricemia. Market Analysis and Insights: Global Amino Acid Metabolism Disease Market The global Amino Acid Metabolism Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 20…
世界の脂質代謝疾患治療市場規模・現状・予測（2021年-2027年） Lipid Metabolism Disease Drug is usually used to help lipid metabolism. Market Analysis and Insights: Global Lipid Metabolism Disease Treatment Market The global Lipid Metabolism Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX%…
世界のアミノ酸代謝疾患治療市場規模・現状・予測（2021年-2027年） Amino Acid Metabolism Drug is used to treat the gout and Hyperuricemia. Market Analysis and Insights: Global Amino Acid Metabolism Disease Treatment Market The global Amino Acid Metabolism Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a C…